Management Presentation: Biosimilar Pipeline and Margin Improvement Strategy

We have a clear purpose to pioneer access for patients to become the world's leading and most valued Generics and Biosimilars company Purpose Vision Impact 5 Pioneering access for patients Becoming the world's leading and most valued Generics and Biosimilars company ~500 million 1 >USD 180 billion² patients served per annum estimated annual social impact of Sandoz medicines 1. Based on internal analysis, 2. Based on 2022 WifOR Institute analysis. SANDOZ

View entire presentation